A Study of Plitidepsin in Patients With Relapsed or Refractory Angioimmunoblastic T-cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Lymphoma
Related studies linked through entity extraction aliases.
The Effects of Anthracycline-based Chemotherapy on Peripheral Vascular Function
- Status
- COMPLETED
- Phase
- N/A
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- N/A
A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Using Telephone Counselling to Improve Exercise Participation in Hematologic Cancer Survivors
- Status
- COMPLETED
- Phase
- NA
Study Evaluating Safety and Efficacy of INCB050465 Combined With Bendamustine and Obinutuzumab in Relapsed or Refractory Follicular Lymphoma (CITADEL-102)
- Status
- COMPLETED
- Phase
- PHASE1
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1
Umbilical Cord Blood Transplantation From Unrelated Donors
- Status
- RECRUITING
- Phase
- N/A
PROCLAIM-CX-072: A Trial to Find Safe and Active Doses of an Investigational Drug CX-072 for Patients With Solid Tumors or Lymphomas
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- PHASE4
Study of Ulevostinag (MK-1454) Alone or in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Tripegfilgrastim in Pediatric Solid Tumor/Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1
Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE2
Helicobacter Pylori Antibiotic Susceptibility Testing of Korea
- Status
- UNKNOWN
- Phase
- N/A
A Clinical Research of CD30-Targeted CAR-T in Lymphocyte Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2